Joseph started his career as a scientist, developing new cancer therapies during his PhD at the University of Toronto. He co-founded a medical device startup during his studies which brought him into the world of business and his first interactions with VCs.
He first learned about active investing during his time at DM Capital in Shenzhen, helping launch their first fund, Harmony. He then joined Oliver Wyman’s health and life sciences practice to understand and develop strategies towards addressing key business and market needs for his global healthcare clients, and did so for over 75 projects, and across 20+ markets. During this time he also assisted several funds and conglomerates with their healthcare investment strategies.
Seeing the need for more early stage investment for healthcare founders, and the opportunity for technology to make a real difference, Joseph began angel investing in health tech companies in 2014, eventually reaching a personal portfolio of 9 companies by 2018. It was at that point that Joseph realised that he needed to do this full time and that there weren't any funds out there that were focused on seed stage, health tech, and massive solving global problems, which is when he decided to launch Verge HealthTech later that year.